OraSure Technologies Inc (OSUR)
5.245
+0.02
(+0.48%)
USD |
NASDAQ |
Apr 17, 15:40
OraSure Technologies Price: 5.245 for April 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 16, 2024 | 5.39 | 5.39 | 5.22 | 5.22 | 542599.0 |
Apr 15, 2024 | 5.52 | 5.56 | 5.395 | 5.41 | 660224.0 |
Apr 12, 2024 | 5.74 | 5.745 | 5.49 | 5.52 | 418379.0 |
Apr 11, 2024 | 5.81 | 5.84 | 5.75 | 5.77 | 430094.0 |
Apr 10, 2024 | 5.82 | 5.83 | 5.72 | 5.79 | 676650.0 |
Apr 09, 2024 | 5.95 | 6.045 | 5.85 | 5.93 | 761646.0 |
Apr 08, 2024 | 5.96 | 5.99 | 5.84 | 5.92 | 828266.0 |
Apr 05, 2024 | 5.79 | 6.05 | 5.77 | 5.96 | 929517.0 |
Apr 04, 2024 | 6.20 | 6.35 | 6.00 | 6.01 | 764499.0 |
Apr 03, 2024 | 6.00 | 6.19 | 5.94 | 6.18 | 906412.0 |
Apr 02, 2024 | 6.01 | 6.05 | 5.85 | 6.01 | 898152.0 |
Apr 01, 2024 | 6.16 | 6.265 | 6.08 | 6.08 | 638086.0 |
Mar 28, 2024 | 6.15 | 6.23 | 6.095 | 6.15 | 1.184M |
Mar 27, 2024 | 6.11 | 6.25 | 6.09 | 6.14 | 739040.0 |
Mar 26, 2024 | 6.28 | 6.355 | 6.08 | 6.08 | 626838.0 |
Mar 25, 2024 | 6.35 | 6.375 | 6.13 | 6.22 | 773730.0 |
Mar 22, 2024 | 6.31 | 6.37 | 6.225 | 6.32 | 707590.0 |
Mar 21, 2024 | 6.51 | 6.58 | 6.34 | 6.34 | 1.000M |
Mar 20, 2024 | 6.68 | 6.69 | 6.43 | 6.52 | 619326.0 |
Mar 19, 2024 | 6.76 | 6.825 | 6.59 | 6.73 | 730718.0 |
Mar 18, 2024 | 6.70 | 6.96 | 6.66 | 6.80 | 1.229M |
Mar 15, 2024 | 6.83 | 6.97 | 6.62 | 6.65 | 8.104M |
Mar 14, 2024 | 7.03 | 7.13 | 6.87 | 6.88 | 1.087M |
Mar 13, 2024 | 7.03 | 7.20 | 6.975 | 7.03 | 757395.0 |
Mar 12, 2024 | 6.89 | 7.125 | 6.89 | 7.06 | 861033.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.71
Minimum
Jun 30 2022
19.58
Maximum
Aug 05 2020
8.319
Average
7.89
Median
Dec 09 2019
Price Benchmarks
Abbott Laboratories | 105.85 |
Integra Lifesciences Holdings Corp | 31.85 |
Insulet Corp | 167.97 |
Perspective Therapeutics Inc | 1.415 |
Xtant Medical Holdings Inc | 0.8001 |
Price Related Metrics
PE Ratio | 7.285 |
PS Ratio | 0.9592 |
Price to Book Value | 0.8988 |
Price to Free Cash Flow | 2.963 |
Earnings Yield | 13.73% |
Market Cap | 387.06M |
Operating PE Ratio | 8.958 |
Normalized PE Ratio | 6.206 |